Filter Results:
(1,327)
Show Results For
- All HBS Web
(1,327)
- People (2)
- News (344)
- Research (765)
- Events (2)
- Multimedia (5)
- Faculty Publications (392)
Show Results For
- All HBS Web
(1,327)
- People (2)
- News (344)
- Research (765)
- Events (2)
- Multimedia (5)
- Faculty Publications (392)
- January 1993 (Revised October 1993)
- Case
Medtronic, Inc.
In 1991, Bill George, CEO of Medtronic, the world's largest manufacturer of pacemakers, was evaluating his strategic options in light of the changing economic environment. In the United States, Europe, and Japan, governments were considering regulatory changes to... View Details
Keywords: Diversification; Corporate Strategy; Health Care and Treatment; Policy; Medical Devices and Supplies Industry
Goodman, John B., and Patrick Moreton. "Medtronic, Inc." Harvard Business School Case 793-058, January 1993. (Revised October 1993.)
- 02 Oct 2017
- News
SCOTUS and the Duopoly's Deadlock — CEO Daily, Monday, 2nd October
- April 2023 (Revised July 2023)
- Case
Fermenting Accounting Problems at Vermont Kombucha Corp.
By: Tatiana Sandino and Marshal Herrmann
Founded in 2005, Vermont Kombucha Corp. (V-Ko) was an early mover in the fledgling U.S. market for kombucha, a drink brewed for its health benefits. Early on, the company captured more than 90% of market share. Under the leadership of its founder and CEO, Joe Williams,... View Details
Keywords: Going Public; Business Model; Financial Reporting; Ethics; Corporate Governance; Stock Shares; Food and Beverage Industry
Sandino, Tatiana, and Marshal Herrmann. "Fermenting Accounting Problems at Vermont Kombucha Corp." Harvard Business School Case 123-064, April 2023. (Revised July 2023.)
- Career Coach
Judy Shen-Filerman
Judy (HBS '94) has a passion for helping students shape their career vision, improve their storytelling and be effective communicators in US corporate culture. Judy’s coaching firm specializes in developing professionals from non-US... View Details
- 27 Nov 2012
- Working Paper Summaries
No Margin, No Mission? A Field Experiment on Incentives for Pro-Social Tasks
Clayton S. Rose
Clayton Rose is Baker Foundation Professor of Management Practice. He currently teaches the course Accountability in the Advanced Management Program. His research is focused on the how leaders can manage the challenges created by the intense, varied and often... View Details
Keywords: financial services
Reza R. Satchu
Reza Satchu is a Senior Lecturer in the Entrepreneurship Management Unit at the Harvard Business School where he teaches The Entrepreneurial Manager, The Founder Mindset and Founder Launch. He is also the Founder, Managing Partner and majority shareholder of... View Details
- Program
Advanced Management Program
financing, and outperforming the competition Deploy a broadly informed global perspective as you evaluate markets, analyze competitive forces, and establish corporate strategy Navigate the global financial system while capturing... View Details
- 15 Jan 2013
- First Look
First Look: January 15
PublicationsThe Future of Organization Design Authors:Baldwin, Carliss Y. Publication:Journal of Organization Design Abstract The modern corporation has long been the central focus of the field of organization design. Such firms can be... View Details
Keywords: Sean Silverthorne
- 17 Dec 2007
- Research & Ideas
The Rise of Medical Tourism
describes, the globalization of health care also provides a fascinating angle on globalization generally and is of great interest to corporate strategists. "Apollo Hospitals—First-World View Details
- September 2003
- Case
Allscripts, Inc.
By: William A. Sahlman and Laurence E. Katz
Describes a set of decisions confronting an entrepreneurial team that is considering taking managerial control of Allscripts, a health care venture. The company has gone through nine rounds of external financing and has changed its business model several times. View Details
Keywords: Business Model; Business or Company Management; Venture Capital; Corporate Entrepreneurship; Health Care and Treatment; Corporate Finance; Health Industry
Sahlman, William A., and Laurence E. Katz. "Allscripts, Inc." Harvard Business School Case 804-053, September 2003.
Joshua D. Margolis
Joshua Margolis is James Dinan and Elizabeth Miller Professor of Business Administration and the Unit Head for the Organizational Behavior unit. He is also Faculty Chair of the Program for Leadership Development. His research and teaching revolve around leadership... View Details
- November 29, 2005
- Comment
Transparency Needed in Berkeley Lab Nanotechnology
Argues that the Lawrence Berkeley National Laboratory should be significantly more transparent about the health and environmental issues associated with its new nanotechnology facility. View Details
Toffel, Michael W. "Transparency Needed in Berkeley Lab Nanotechnology." Berkeley Daily Planet (November 29, 2005).
- August 2016 (Revised August 2016)
- Teaching Note
Intrapreneurship at DaVita Healthcare Partners
By: Joseph B. Fuller and Matthew Preble
DaVita Healthcare Partners Inc. (DaVita) is one of the U.S.'s leading dialysis providers, a process whereby persons with end-stage renal disease (ESRD) are connected to a machine that performs the functions of a healthy kidney. Kent Thiry, DaVita's CEO, has expanded... View Details
- 06 Jun 2023
- Cold Call Podcast
The Opioid Crisis, CEO Pay, and Shareholder Activism
- March 2010
- Supplement
Whose Money Is It Anyway? (C)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The case describes how the Brigham and Women's Physicians Organization and its corporate parent resolved the issue of how the disputed funds would be distributed and used. View Details
Keywords: Corporate Governance; Business Subsidiaries; Organizational Design; Conflict and Resolution; Resource Allocation; Health Industry
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (C)." Harvard Business School Supplement 810-031, March 2010.
- Program
General Management Program
organization, the program delivers the tools you need to capitalize on technological disruption and digital transformation and play a more strategic role in corporate success. This includes: Read More Considering global and industry... View Details
- Article
Four Things No One Will Tell You About ESG Data
By: Sakis Kotsantonis and George Serafeim
As the ESG finance field and the use of ESG data in investment decision-making continue to grow, the authors seek to shed light on several important aspects of ESG measurement and data. This article is intended to provide a useful guide for the rapidly rising number of... View Details
Keywords: ESG; ESG (Environmental, Social, Governance) Performance; ESG Reporting; Data Analytics; Sustainability; Sustainability Reporting; CSR; Transparency; Investment Management; Socially Responsible Investing; Sustainable Finance; Sustainable Development; Inclusion; Inclusive Growth; Corporate Social Responsibility and Impact; Corporate Accountability; Investment; Management; Climate Change; Corporate Governance; Diversity; Integrated Corporate Reporting
Kotsantonis, Sakis, and George Serafeim. "Four Things No One Will Tell You About ESG Data." Journal of Applied Corporate Finance 31, no. 2 (Spring 2019): 50–58.
- January 2003 (Revised May 2003)
- Case
Heineken NV: Workplace HIV/AIDS Programs in Africa (B)
Second in a three-part series that explores the multifaceted organizational and strategic choices that companies now face as a result of the global AIDS epidemic. Heineken is considering becoming one of the first companies to offer AIDS drugs (antiretroviral therapy)... View Details
Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Food and Beverage Industry; Africa
Barrett, Diana, and Daniella Ballou. "Heineken NV: Workplace HIV/AIDS Programs in Africa (B)." Harvard Business School Case 303-064, January 2003. (Revised May 2003.)
- October 2021 (Revised October 2022)
- Case
The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged had contributed to the nationwide... View Details
Keywords: Opioids; Drug; Investors; Shareholder Activism; Investment Activism; Executive Compensation; Corporate Accountability; Corporate Governance; Governance Compliance; Governance Controls; Risk Management; Corporate Social Responsibility and Impact; Business and Shareholder Relations; Business and Stakeholder Relations; Legal Liability; Health Industry; Health Industry; Health Industry; United States; West Virginia; Tennessee; Ohio; Pennsylvania
Srinivasan, Suraj, and Li-Kuan Ni. "The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen." Harvard Business School Case 122-014, October 2021. (Revised October 2022.)